Treatment-Resistant Depression: What Your Options Are
Quick answer
Treatment-resistant depression is commonly defined as inadequate response after at least two adequate antidepressant trials, although definitions vary. Next steps can include diagnostic re-assessment, medication changes, psychotherapy, and clinic procedures considered by a psychiatrist. It is a recognised medical situation, not a dead end.
Treatment-resistant depression usually means depression that has not improved adequately after trials of at least two different antidepressants at proper dose and duration. It is not a dead end: psychiatrists have a defined menu of next steps—reviewing the diagnosis, changing or combining medications, intensifying therapy, and clinic-based options such as ECT, TMS, and ketamine-based treatment.
If you are reading this because months of treatment have not moved the weight, the most important sentence comes first: this is a recognised medical situation with recognised medical answers, handled by psychiatrists every week, including in India. This guide walks the option list in order.
What "treatment-resistant" actually means
The label describes the depression's response to treatment so far—not your effort, willpower, or worth. Definitions vary slightly, but the common working version, used by bodies like the US National Institute of Mental Health, is inadequate improvement after two or more adequate antidepressant trials: right dose, right duration, actually taken.
That last clause matters. Before the label applies, a psychiatrist checks the basics: Was each trial long enough—typically several weeks at a therapeutic dose? Were doses ever adjusted upward? Did side effects interrupt the course? Honest answers here sometimes reveal that the treatment was never fully tried, which is fixable news, not embarrassing news.
Step one: the re-assessment
Good psychiatrists respond to non-response by re-asking the diagnostic questions. Is this actually bipolar depression, which responds differently to standard antidepressants and needs its own approach—see our separate guide? Is a thyroid problem, anaemia, or another medical condition dragging mood? Is alcohol or another substance quietly working against the treatment? Is untreated anxiety, trauma, or an ongoing life situation—an abusive home, crushing debt—holding the depression in place?
Each of those has a different fix, and each is found by assessment rather than by another identical prescription. If your current doctor is not re-assessing after repeated non-response, seeking a second psychiatric opinion is reasonable and normal.
The medical options after two failed trials
| Option | What it involves | Notes |
|---|---|---|
| Switching medication | Moving to a different antidepressant, often a different class | Common next step; needs weeks to evaluate |
| Augmentation | Adding a second medication to boost the first | A psychiatrist-managed strategy with monitoring |
| Intensified psychotherapy | Structured CBT or similar alongside medication | Evidence supports combining even after medication alone fails |
| ECT | Hospital procedure under anaesthesia | Among the most effective options for severe resistant depression |
| TMS | Non-invasive magnetic stimulation in clinic sessions | Established for depression that has not responded to medication |
| Ketamine-based treatment | Clinic-administered, psychiatrist-supervised | Rapid-acting option in specialised settings; see our guide |
Order and choice are individual—driven by severity, safety, history, availability, and your own preferences after a proper risks-and-benefits conversation. Our detailed guides on ECT, TMS, and ketamine treatment explain what each procedure actually feels like and what the evidence says.
Accessing these options in India
Government teaching hospitals and specialist psychiatric services can assess treatment-resistant depression and determine whether brain-stimulation or other clinic-based options are appropriate. Availability varies by institution and city, so ask the treating psychiatrist what is actually offered locally and what a referral would involve.
Costs range from near-free in government settings to significant in private clinics. Ask for the full course cost, not the per-session figure, and check current insurance terms for psychiatric procedures—policies differ and change.
Holding on while the next option loads
Non-response is exhausting in a way single-episode depression is not: hope itself gets tired. Protect the basics harder than ever—fixed wake time, daily movement, real food, one honest human conversation a week. Keep a simple written log of mood, sleep, and side effects; it turns your next appointment from vague recollection into usable data.
And keep the frame accurate: you have a condition that has not yet responded, being treated by a field with several remaining moves. People come out the other side of exactly this situation constantly, including via the options in the table above.
Where Boli fits when treatment is hard
The months of treatment-resistant depression are heavy on the hours no appointment covers. Boli's Maya, Priya, and Neha are Hinglish AI companions for those hours—a place to say "aaj bhi kuch feel nahi hua" out loud, to unload the frustration of another medication change, or to rehearse telling family why treatment is taking longer than they expected.
An AI companion cannot treat resistant depression or advise on medication. What it can do is keep you talking during a phase whose main danger is going silent.
When to seek help immediately
Treatment-resistant does not mean crisis-resistant—if thoughts of self-harm or suicide arrive, they are treatable and urgent. Call Tele-MANAS at 14416; in an emergency, call 112 or reach the nearest emergency department. Tell your treating psychiatrist about any such thoughts at the next contact, even if the moment passed.
Frequently Asked Questions
How common is treatment-resistant depression?
A substantial minority of people treated for depression do not respond adequately to the first or second medication—it is common enough that psychiatry has standard pathways for it. Non-response says nothing about your effort and does not predict that nothing will work.
Should I stop antidepressants if they are not working?
Not on your own. Stopping abruptly can cause discontinuation symptoms and remove any partial benefit. Tell your psychiatrist the medication is not helping; switching or augmenting safely is precisely their job.
Which works better for resistant depression: ECT, TMS, or ketamine?
They fit different situations: ECT has the strongest track record for severe or life-threatening depression, TMS is non-invasive and clinic-based, and ketamine-based treatment can act quickly in specialised settings. The right one depends on your history and safety profile—a psychiatrist's comparison, not a ranking chart.
Can Boli help with treatment-resistant depression?
Boli can support you emotionally through the long middle of it—an AI companion to talk to between appointments. It cannot treat the condition or replace the psychiatrist steering the next options. Use both in their lanes.
Two failed medication trials is the start of a defined medical pathway, not the end of the road: re-assessment, switching, augmentation, combined therapy, and clinic options like ECT, TMS, and ketamine remain. Get the re-assessment, ask what exists in your city, and keep one honest log and one honest listener through the middle.
The Depression Treatment Ladder
- Ketamine therapy in India — The rapid-acting clinic option, honestly explained.
- ECT, explained without myths — The strongest option for severe resistant cases.
- TMS therapy in India — Non-invasive stimulation: evidence and costs.
- MDD treatment guide — The full ladder from first assessment onward.
Sources checked
Reviewed on 2026-07-11. Product details can change; open the official page before making a decision.
Talk to Platform about this
Boli’s Platform AI companion can help you organise what you feel or rehearse the next sentence. This is emotional support, not therapy or emergency care.
Start with Platform AI